Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Wockhardt Limited

Market Cap 19TCr 201.74Cr 174Cr 160.23Cr 150.45Cr 282.21Cr 285.34Cr 1.89TCr 739.24Cr 9.34TCr 756.98Cr 740.9Cr 32TCr P/E Ratio 2024
-18.2x
P/E Ratio 2025 -472x
Enterprise Value 21TCr 216.87Cr 187.05Cr 172.25Cr 161.73Cr 303.38Cr 306.74Cr 2.03TCr 794.69Cr 10TCr 813.77Cr 796.47Cr 35TCr EV / Sales 2024
3.82x
EV / Sales 2025 8.1x
Free-Float
48.98%
Yield 2024 *
-
Yield 2025 -
1 day-1.57%
1 week-0.69%
Current month-6.09%
1 month+23.29%
3 months+57.48%
6 months+42.23%
Current year+31.90%
1 week 1,820
Extreme 1820
1,978
1 month 1,522.6
Extreme 1522.6
2,422.3
Current year 1,086.7
Extreme 1086.7
2,422.3
1 year 1,086.7
Extreme 1086.7
2,422.3
3 years 193
Extreme 193
2,422.3
5 years 145.15
Extreme 145.15
2,422.3
10 years 145.15
Extreme 145.15
2,422.3
Manager TitleAgeSince
Chief Executive Officer 53 01/04/2009
Director of Finance/CFO - 01/03/2022
Chief Tech/Sci/R&D Officer - 01/05/1998
Director TitleAgeSince
Chairman 83 06/11/2009
Director/Board Member 73 29/08/2020
Director/Board Member 53 06/11/2009
Change 5-day change 1-year change 3-year change Capi.($)
-1.57%-0.69%+7.40%+911.45% 331.31Cr
-0.09%+1.34%+7.00%+83.03% 4.56TCr
+0.29%-3.31%+41.08%+82.87% 3.35TCr
-0.58%-1.43%-8.23%+41.14% 1.18TCr
-1.50%-0.08%+11.61%+104.40% 1.17TCr
+1.54%+3.53%+40.43%+135.71% 912.1Cr
+1.59%+1.68%+20.24%+44.80% 716.41Cr
+2.37%+1.80%+45.10%-15.41% 649.02Cr
-0.79%-0.44%+29.15%+238.32% 645.39Cr
+0.06%-2.97%-43.02%-3.42% 515.65Cr
Average +0.13%+0.18%+15.07%+162.29% 1.4TCr
Weighted average by Cap. +0.09%-0.14%+18.04%+101.69%

Financials

2024 2025
Net sales 2.83TCr 30Cr 26Cr 24Cr 22Cr 42Cr 42Cr 280.35Cr 109.51Cr 1.38TCr 112.14Cr 109.75Cr 4.79TCr 3.04TCr 32Cr 28Cr 25Cr 24Cr 45Cr 45Cr 300.66Cr 117.44Cr 1.48TCr 120.26Cr 117.7Cr 5.14TCr
Net income -463Cr -4.89Cr -4.22Cr -3.88Cr -3.65Cr -6.84Cr -6.92Cr -46Cr -18Cr -226.26Cr -18Cr -18Cr -784.04Cr -47Cr -49.63L -42.81L -39.42L -37.01L -69.43L -70.2L -4.66Cr -1.82Cr -23Cr -1.86Cr -1.82Cr -80Cr
Net Debt 1.83TCr 19Cr 17Cr 15Cr 14Cr 27Cr 27Cr 181.58Cr 71Cr 895.74Cr 73Cr 71Cr 3.1TCr 1.43TCr 15Cr 13Cr 12Cr 11Cr 21Cr 21Cr 141.96Cr 55Cr 700.27Cr 57Cr 56Cr 2.43TCr
Logo Wockhardt Limited
Wockhardt Limited is a research-based global pharmaceutical and biotech company. The Company is engaged in the pharmaceutical business. It focuses on the unmet need for antibacterial drugs that are effective against the menace of untreatable superbugs. It manufactures and supplies branded and generic finished formulations, as well as intermediate products like active pharmaceutical ingredients (APIs), worldwide. The Company’s products in India include EMROK, MERIWOK, REINVEXIN, ERLISO, METHYCOBAL 500 MCG 15T, METHYCOBAL INJ 1 ML, METHYCOBAL D 10T, HAPID 10C, PROXYFEN NANO GEL, LIVATIRA 500 10T NEW PACK, LIVATIRA INJ 5 ml, GABAWOK NT 100MG 15T, GABAWOK NT 400MG 15T, ETOBRIX 90 MG 10C, ETOBRIX TH 4 10C, ETOBRIX P 10T, GLARZEN 100IU, TERITIDE, GLIMADAY HS, GLIMADAY FORTE-2, GLIMADAY FORTE-1, GLIMADAY FORTE 3, GLIMADAY 2 mg, GLIMADAY 1 mg, MOPADAY FORTE, INOGLA, WEPOX 4000 IU 1ML, MYCORAL M, Val 450, OKERON INJ 100MCG 1ML, DARBOTIN 40, and DARBOTIN 60.
Employees
2,296
Date Price Change Volume
15/26/15 1,907.60 -1.57% 13,73,455
12/26/12 1,938.00 +0.74% 12,73,816
11/26/11 1,923.80 +4.95% 33,09,525
10/26/10 1,833.00 -2.89% 14,11,114
09/26/09 1,887.60 -0.28% 20,67,688
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
BB
  1. Stock Market
  2. Stocks
  3. WOCKPHARMA Stock
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!